Polycystic ovary syndrome: insulin resistance as the shared mechanism, ovulatory and menstrual outcomes reported on treatment, androgen changes, and contraception considerations during rapid weight loss.
Anovulatory for most of my adult life with PCOS, told repeatedly that conception would be difficult and would need assistance. Five months into treatment, having lost…
Numbers first: cagrilintide · SURMOUNT-2. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
Diagnosed with PCOS at 24, now 31, BMI 34. I have been told for years that losing weight will improve my symptoms, and separately that insulin resistance is the…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I want the working, not the result — I need to be able to redo it…
Baseline, before starting treatment: total testosterone 2.6 nmol/L, SHBG 22 nmol/L. After eight months and 16 kg of weight loss: total testosterone 1.9 nmol/L, SHBG…
I have three data points across nine months, which I hope is enough to see a trend. I can parse the result. I am less sure what it licenses me to conclude. I have…
For reference: FLOW · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
Conditions: STEP 4 · fatigue · 5 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
For reference: SOUL · 60 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
Stated plainly: PIONEER-1 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Stated plainly: nausea · a GLP-1 receptor agonist · STEP 8. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
What I have: eGFR · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work matters.…
Setup, so nobody has to ask: ALT · a GLP-1 receptor agonist. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
The particulars: SUSTAIN-6 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse results